AMN Healthcare (AMN) Reiterated at Market Outperform by Citizens as Recovery Continues
Citizens analyst Constantine Davides reiterated a Market Outperform rating and $36.00 price target on AMN Healthcare (NYSE: AMN).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
